human prlr Search Results


prolactin receptor  (Sino Biological)
90
Sino Biological prolactin receptor
Prolactin Receptor, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prolactin receptor/product/Sino Biological
Average 90 stars, based on 1 article reviews
prolactin receptor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human il 18  (Multi Sciences (Lianke) Biotech Co Ltd)
90
Multi Sciences (Lianke) Biotech Co Ltd human il 18
Human Il 18, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 18/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 90 stars, based on 1 article reviews
human il 18 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human prlr  (Sino Biological)
90
Sino Biological human prlr
Human Prlr, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prlr/product/Sino Biological
Average 90 stars, based on 1 article reviews
human prlr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
the anti-prlr antibody against human prlr ecd  (Genzyme)
90
Genzyme the anti-prlr antibody against human prlr ecd
The Anti Prlr Antibody Against Human Prlr Ecd, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the anti-prlr antibody against human prlr ecd/product/Genzyme
Average 90 stars, based on 1 article reviews
the anti-prlr antibody against human prlr ecd - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse monoclonal antibodies against human prlr  (AnaSpec)
90
AnaSpec mouse monoclonal antibodies against human prlr
A. RT-PCR analysis. Total RNA was isolated from normal pituitary tissue (Pit), normal endometrium (Normal), non-tumor adjacent tissue surrounding endometrial (Endo) and ovarian tumors (NAT), and endometrial and ovarian tumors (Tumor). P-proximal transcript, expected size of 617bp (red rectangle); D-distal transcript, expected size of 780bp (blue rectangle). B. Prolactin expression by endometrial and ovarian carcinoma. Ovarian carcinoma cells, OVCAR3 and SKOV3, and endometrial carcinoma cells, HEC-1A, AN3 CA, and RL95-2 were stained with <t>anti-PRL</t> <t>monoclonal</t> Ab. Isotype-matched nonspecific Ab produced no staining (not shown); C. Expression of prolactin receptor in four human carcinoma cell lines. Cells were stained with rabbit polyclonal anti-PRLR Ab. Surface expression of prolactin receptor was measured by flow cytometry. Horizontal bars indicate SE. D. Expression of prolactin receptor in tumors and healthy tissues. Ovarian cancer, endometrial cancer, and endometrial progression (hyperplasia) TMAs were stained with anti-PRLR antibody. Representative cores are presented.
Mouse Monoclonal Antibodies Against Human Prlr, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibodies against human prlr/product/AnaSpec
Average 90 stars, based on 1 article reviews
mouse monoclonal antibodies against human prlr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse monoclonal antibodies against human prl and prlr  (AnaSpec)
90
AnaSpec mouse monoclonal antibodies against human prl and prlr
A. RT-PCR analysis. Total RNA was isolated from normal pituitary tissue (Pit), normal endometrium (Normal), non-tumor adjacent tissue surrounding endometrial (Endo) and ovarian tumors (NAT), and endometrial and ovarian tumors (Tumor). P-proximal transcript, expected size of 617bp (red rectangle); D-distal transcript, expected size of 780bp (blue rectangle). B. Prolactin expression by endometrial and ovarian carcinoma. Ovarian carcinoma cells, OVCAR3 and SKOV3, and endometrial carcinoma cells, HEC-1A, AN3 CA, and RL95-2 were stained with <t>anti-PRL</t> <t>monoclonal</t> Ab. Isotype-matched nonspecific Ab produced no staining (not shown); C. Expression of prolactin receptor in four human carcinoma cell lines. Cells were stained with rabbit polyclonal anti-PRLR Ab. Surface expression of prolactin receptor was measured by flow cytometry. Horizontal bars indicate SE. D. Expression of prolactin receptor in tumors and healthy tissues. Ovarian cancer, endometrial cancer, and endometrial progression (hyperplasia) TMAs were stained with anti-PRLR antibody. Representative cores are presented.
Mouse Monoclonal Antibodies Against Human Prl And Prlr, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibodies against human prl and prlr/product/AnaSpec
Average 90 stars, based on 1 article reviews
mouse monoclonal antibodies against human prl and prlr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
double-stranded sirna targeting human prlr  (Shanghai GenePharma)
90
Shanghai GenePharma double-stranded sirna targeting human prlr
A. RT-PCR analysis. Total RNA was isolated from normal pituitary tissue (Pit), normal endometrium (Normal), non-tumor adjacent tissue surrounding endometrial (Endo) and ovarian tumors (NAT), and endometrial and ovarian tumors (Tumor). P-proximal transcript, expected size of 617bp (red rectangle); D-distal transcript, expected size of 780bp (blue rectangle). B. Prolactin expression by endometrial and ovarian carcinoma. Ovarian carcinoma cells, OVCAR3 and SKOV3, and endometrial carcinoma cells, HEC-1A, AN3 CA, and RL95-2 were stained with <t>anti-PRL</t> <t>monoclonal</t> Ab. Isotype-matched nonspecific Ab produced no staining (not shown); C. Expression of prolactin receptor in four human carcinoma cell lines. Cells were stained with rabbit polyclonal anti-PRLR Ab. Surface expression of prolactin receptor was measured by flow cytometry. Horizontal bars indicate SE. D. Expression of prolactin receptor in tumors and healthy tissues. Ovarian cancer, endometrial cancer, and endometrial progression (hyperplasia) TMAs were stained with anti-PRLR antibody. Representative cores are presented.
Double Stranded Sirna Targeting Human Prlr, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/double-stranded sirna targeting human prlr/product/Shanghai GenePharma
Average 90 stars, based on 1 article reviews
double-stranded sirna targeting human prlr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
prlr isoform expression  (Cooperative Human Tissue Network (CHTN)
90
Cooperative Human Tissue Network (CHTN prlr isoform expression
Characterization of <t>PRLR</t> <t>isoform</t> antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.
Prlr Isoform Expression, supplied by Cooperative Human Tissue Network (CHTN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prlr isoform expression/product/Cooperative Human Tissue Network (CHTN
Average 90 stars, based on 1 article reviews
prlr isoform expression - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human prolactin receptor gene orf cdna clone expression plasmid  (Sino Biological)
90
Sino Biological human prolactin receptor gene orf cdna clone expression plasmid
Characterization of <t>PRLR</t> <t>isoform</t> antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.
Human Prolactin Receptor Gene Orf Cdna Clone Expression Plasmid, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prolactin receptor gene orf cdna clone expression plasmid/product/Sino Biological
Average 90 stars, based on 1 article reviews
human prolactin receptor gene orf cdna clone expression plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
prolactin receptor (prlr) human shrna plasmid kit  (OriGene)
90
OriGene prolactin receptor (prlr) human shrna plasmid kit
Characterization of <t>PRLR</t> <t>isoform</t> antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.
Prolactin Receptor (Prlr) Human Shrna Plasmid Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prolactin receptor (prlr) human shrna plasmid kit/product/OriGene
Average 90 stars, based on 1 article reviews
prolactin receptor (prlr) human shrna plasmid kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human prlr plasmid  (Inserm Transfert)
90
Inserm Transfert human prlr plasmid
Characterization of <t>PRLR</t> <t>isoform</t> antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.
Human Prlr Plasmid, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prlr plasmid/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
human prlr plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A. RT-PCR analysis. Total RNA was isolated from normal pituitary tissue (Pit), normal endometrium (Normal), non-tumor adjacent tissue surrounding endometrial (Endo) and ovarian tumors (NAT), and endometrial and ovarian tumors (Tumor). P-proximal transcript, expected size of 617bp (red rectangle); D-distal transcript, expected size of 780bp (blue rectangle). B. Prolactin expression by endometrial and ovarian carcinoma. Ovarian carcinoma cells, OVCAR3 and SKOV3, and endometrial carcinoma cells, HEC-1A, AN3 CA, and RL95-2 were stained with anti-PRL monoclonal Ab. Isotype-matched nonspecific Ab produced no staining (not shown); C. Expression of prolactin receptor in four human carcinoma cell lines. Cells were stained with rabbit polyclonal anti-PRLR Ab. Surface expression of prolactin receptor was measured by flow cytometry. Horizontal bars indicate SE. D. Expression of prolactin receptor in tumors and healthy tissues. Ovarian cancer, endometrial cancer, and endometrial progression (hyperplasia) TMAs were stained with anti-PRLR antibody. Representative cores are presented.

Journal:

Article Title: Biological Significance of Prolactin in Gynecological Cancers

doi: 10.1158/0008-5472.CAN-08-4652

Figure Lengend Snippet: A. RT-PCR analysis. Total RNA was isolated from normal pituitary tissue (Pit), normal endometrium (Normal), non-tumor adjacent tissue surrounding endometrial (Endo) and ovarian tumors (NAT), and endometrial and ovarian tumors (Tumor). P-proximal transcript, expected size of 617bp (red rectangle); D-distal transcript, expected size of 780bp (blue rectangle). B. Prolactin expression by endometrial and ovarian carcinoma. Ovarian carcinoma cells, OVCAR3 and SKOV3, and endometrial carcinoma cells, HEC-1A, AN3 CA, and RL95-2 were stained with anti-PRL monoclonal Ab. Isotype-matched nonspecific Ab produced no staining (not shown); C. Expression of prolactin receptor in four human carcinoma cell lines. Cells were stained with rabbit polyclonal anti-PRLR Ab. Surface expression of prolactin receptor was measured by flow cytometry. Horizontal bars indicate SE. D. Expression of prolactin receptor in tumors and healthy tissues. Ovarian cancer, endometrial cancer, and endometrial progression (hyperplasia) TMAs were stained with anti-PRLR antibody. Representative cores are presented.

Article Snippet: Mouse monoclonal antibodies against human PRL (catalog no. 53797) and PRLR (catalog no. 53799) were from AnaSpec (San Jose, CA), and Ras inhibitor, α-hydroxy farnesyl phosphonic acid was from Cayman Chemicals (Ann Arbor, MI).

Techniques: Reverse Transcription Polymerase Chain Reaction, Isolation, Expressing, Staining, Produced, Flow Cytometry

Characterization of PRLR isoform antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.

Journal: BMC Cancer

Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

doi: 10.1186/1471-2407-10-678

Figure Lengend Snippet: Characterization of PRLR isoform antibodies. A. Western blot analysis indicating specificity of polyclonal antibodies. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Cell lysates were prepared and proteins separated by PAGE. Each isoform specific lysate was probed with each isoform specific antibody. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. Molecular weights are marked as indicated: LF = 93 kDa, SF1a = 57 kDa, SF1b = 38 kDa. Cell lysates from CHO transfected cells were immunoprecipitated with their respective antibodies, then immunoblotted with the same antibodies. Each transfection was performed in triplicate and Western blot analysis performed twice. Data shown are a representative autoradiogram. IP indicates immunoprecipitation. B. Western blot analysis using commercially available PRLR antibody. ECD = antibody recognizing extracellular domain C. Fluorescent immunocytochemical analysis. CHO cells were transiently transfected with isoform specific PRLR cDNA as described. Specific staining was observed using isoform specific polyclonal antibodies. The negative control (not shown) lacks primary antibody and appears black. Data shown are representative of triplicate experiments. Magnification 20×.

Article Snippet: PRLR isoform expression was examined on 12 lobular carcinoma and 10 ductal carcinoma specimens obtained from CHTN; other investigators may have received samples from these same tissues.

Techniques: Western Blot, Transfection, Immunoprecipitation, Staining, Negative Control

Immunoanalysis on human xenografts. A. Fluorescent immunohistochemistry was performed on MCF7, MDA-MB-231, or T47D cells which were injected into the cleared fat pads of nude mice; once tumors reached 1 cm 2 (measured in two dimensions), they were excised, formalin fixed, sectioned, and stained with the indicated PRLR isoform specific antibodies. B. Immunohistochemical analysis using DAB as chromogen of MCF7, MDA-MB-231, or T47D xenograft tumors. neg = no primary antibody as negative control; DAPI stain to visualize the presence of cells. Photographs are representative from 5 different tumors for each cell line. Magnification 40×.

Journal: BMC Cancer

Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

doi: 10.1186/1471-2407-10-678

Figure Lengend Snippet: Immunoanalysis on human xenografts. A. Fluorescent immunohistochemistry was performed on MCF7, MDA-MB-231, or T47D cells which were injected into the cleared fat pads of nude mice; once tumors reached 1 cm 2 (measured in two dimensions), they were excised, formalin fixed, sectioned, and stained with the indicated PRLR isoform specific antibodies. B. Immunohistochemical analysis using DAB as chromogen of MCF7, MDA-MB-231, or T47D xenograft tumors. neg = no primary antibody as negative control; DAPI stain to visualize the presence of cells. Photographs are representative from 5 different tumors for each cell line. Magnification 40×.

Article Snippet: PRLR isoform expression was examined on 12 lobular carcinoma and 10 ductal carcinoma specimens obtained from CHTN; other investigators may have received samples from these same tissues.

Techniques: Immunohistochemistry, Injection, Staining, Immunohistochemical staining, Negative Control

Message for PRLR isoforms in breast carcinomas. RNA was extracted from 7 ductal (left) and 7 lobular (right) carcinomas and qPCR was performed. Data shown are the mean +/- SE of delta delta Ct values relative to SF1a expression.

Journal: BMC Cancer

Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

doi: 10.1186/1471-2407-10-678

Figure Lengend Snippet: Message for PRLR isoforms in breast carcinomas. RNA was extracted from 7 ductal (left) and 7 lobular (right) carcinomas and qPCR was performed. Data shown are the mean +/- SE of delta delta Ct values relative to SF1a expression.

Article Snippet: PRLR isoform expression was examined on 12 lobular carcinoma and 10 ductal carcinoma specimens obtained from CHTN; other investigators may have received samples from these same tissues.

Techniques: Expressing

Immunohistochemical analysis from ductal breast tissue arrays. Representative photographs taken of ductal carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 144 individual ductal specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.

Journal: BMC Cancer

Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

doi: 10.1186/1471-2407-10-678

Figure Lengend Snippet: Immunohistochemical analysis from ductal breast tissue arrays. Representative photographs taken of ductal carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 144 individual ductal specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.

Article Snippet: PRLR isoform expression was examined on 12 lobular carcinoma and 10 ductal carcinoma specimens obtained from CHTN; other investigators may have received samples from these same tissues.

Techniques: Immunohistochemical staining, Staining

Immunohistochemical analysis from lobular breast tissue arrays. Representative photographs of lobular carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 104 individual lobular specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.

Journal: BMC Cancer

Article Title: Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

doi: 10.1186/1471-2407-10-678

Figure Lengend Snippet: Immunohistochemical analysis from lobular breast tissue arrays. Representative photographs of lobular carcinoma specimens to demonstrate absent, low, medium, or high amounts of fluorescent red intensity staining. 104 individual lobular specimens were stained with PRLR isoform specific antibodies and analyzed. Scale bar indicates range of red scoring.

Article Snippet: PRLR isoform expression was examined on 12 lobular carcinoma and 10 ductal carcinoma specimens obtained from CHTN; other investigators may have received samples from these same tissues.

Techniques: Immunohistochemical staining, Staining